Skip to main content
OpenTrials

Clinical trial condition

Hypersensitivity, Immediate

Explore clinical trials studying Hypersensitivity, Immediate. Study availability and eligibility vary by location and protocol.

6,736 public trials 631 recruiting studies
Refine in advanced search Browse all conditions

Hypersensitivity, Immediate trial results

Completed

A Study Of GW685698X For The Treatment Of Perennial Allergic Rhinitis In Pediatrics

NCT00116883

Conditions
Hypersensitivity, Hypersensitivity, Immediate, Immune System Diseases, +7 more
Locations
  • GSK Investigational Site Hot Springs, Arkansas, United States
  • GSK Investigational Site Little Rock, Arkansas, United States
  • GSK Investigational Site Long Beach, California, United States
  • GSK Investigational Site Jacksonville, Florida, United States
View Trial Details
Completed

CONCEPT: A 1-Year Comparison Of A Stable Dose Of SERETIDE® Inhaler With An Adjustable Maintenance Dose Of SYMBICORT® Inhaler. SERETIDE® Inhaler is a Trademark of GSK Group of Companies. SYMBICORT® Inhaler is a Trademark of Astra Zeneca.

NCT00479739

Conditions
Asthma, Bronchial Diseases, Hypersensitivity, +6 more
Locations
  • GSK Investigational Site Balmain, New South Wales, Australia
  • GSK Investigational Site Brisbane, Queensland, Australia
  • GSK Investigational Site Kippa-Ring, Queensland, Australia
  • GSK Investigational Site Toorak Gardens, South Australia, Australia
View all 106 locations
View Trial Details

Related conditions